Jul. 29 at 3:02 PM
$MCRB Still here. I didn’t think that they would take it this low, but Wall Street is accumulating on weakness and so will I.
I’m still of firm belief that at or slightly above Nestle’s
$21/share stake is where this will end up, and I’m hoping for a nice CVR on the back end. The irEC results reinforce that Seres is a platform and not a single asset / single indication company.
Recent occurrences:
- Nestle joining MTIG
- Luis Briz Ordieres mentioning the microbiome as Nestle’s future beyond just GI conditions (e.g., immunology) in a recent podcast
- Nestle buying the Seres milestones out, shows a continued dialogue and a working relationship between the two along with Evercore and Lazard as representatives
- Many, many other things pointing that this relationship runs deep
Have patience, and just remember how quickly they can move this stock.
Also, do you really think that this company is worth less than
$50M? Lol
